| Dr.Philli vs Jin | 15–23 | 39.47% |
| Dr.Philli vs Heihachi | 13–18 | 41.94% |
| Dr.Philli vs Law | 13–13 | 50.00% |
| Dr.Philli vs Reina | 15–11 | 57.69% |
| Dr.Philli vs Hwoarang | 13–12 | 52.00% |
| Dr.Philli vs King | 12–12 | 50.00% |
| Dr.Philli vs Kazuya | 9–13 | 40.91% |
| Dr.Philli vs Asuka | 15–7 | 68.18% |
| Dr.Philli vs Dragunov | 9–9 | 50.00% |
| Dr.Philli vs Yoshimitsu | 8–9 | 47.06% |
| Dr.Philli vs Clive | 10–7 | 58.82% |
| Dr.Philli vs Lili | 8–8 | 50.00% |
| Dr.Philli vs Leroy | 8–8 | 50.00% |
| Dr.Philli vs Lidia | 4–12 | 25.00% |
| Dr.Philli vs Eddy | 7–8 | 46.67% |
| Dr.Philli vs Bryan | 6–7 | 46.15% |
| Dr.Philli vs Xiaoyu | 9–3 | 75.00% |
| Dr.Philli vs Jun | 3–9 | 25.00% |
| Dr.Philli vs Paul | 2–8 | 20.00% |
| Dr.Philli vs Devil Jin | 3–6 | 33.33% |
| Dr.Philli vs Leo | 6–3 | 66.67% |
| Dr.Philli vs Lars | 2–7 | 22.22% |
| Dr.Philli vs Azucena | 8–1 | 88.89% |
| Dr.Philli vs Steve | 6–2 | 75.00% |
| Dr.Philli vs Kuma | 5–3 | 62.50% |
| Dr.Philli vs Lee | 4–3 | 57.14% |
| Dr.Philli vs Anna | 3–4 | 42.86% |
| Dr.Philli vs Nina | 2–3 | 40.00% |
| Dr.Philli vs Victor | 2–3 | 40.00% |
| Dr.Philli vs Alisa | 1–2 | 33.33% |
| Dr.Philli vs Zafina | 2–1 | 66.67% |
| Dr.Philli vs Jack-8 | 0–2 | 0.00% |
| Dr.Philli vs Claudio | 2–0 | 100.00% |
| Dr.Philli vs Shaheen | 1–0 | 100.00% |
| Dr.Philli vs Panda | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.